extensive stage small cell lung cancer
Conditions
Interventions
EP regimen chemotherapy
Chinese medicine simulant
Yi Shen Qu Tong Granules
Sponsors
Cancer Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Meet the western medical diagnostic criteria for small cell lung cancer and Chinese medicine diagnostic criteria for renal deficiency and positive deficiency, stasis and toxicity stagnation syndrome; (2) First-line patients with evaluable lesions who have not previously received chemotherapy-targeted and immunotherapy; (3) Small cell lung cancer patients who are to receive =2 cycles of immunization + platinum + etoposide first-line treatment; (4) Uncomplicated or no previous history of other primary malignancies; (5) Age 18-80 years with expected survival >12 months; (6) Kasper score (KPS) = 60; (7) Normal cognitive ability, can cooperate in filling out the questionnaire; (8) Voluntary acceptance of the study protocol and signing of the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Those with severe cardiac or cerebrovascular disease, severe hepatic or renal impairment, or infection; (2) Those who have participated or are participating in other clinical trials within 3 months (3) Those with a history of previous psychiatric disorders such as depression, obsessive-compulsive disorder, or schizophrenia; (4) Those who require simultaneous radiotherapy; (5) Those who are pregnant or breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| progression free survival;tumor marker; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome score ;QLQ-C30;Piper Fatigue Score; | — |
Countries
China
Contacts
Public ContactFeng Li
Cancer Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College
Outcome results
None listed